Evolution Wealth Advisors’s Standard BioTools LAB Stock Holding History

Evolution Wealth Advisors’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.2K	Hold	12,210	–	–	﹤0.01%	176
2025 Q4	$15.6K	Hold	12,210	–	–	﹤0.01%	165
2025 Q3	$15.9K	Hold	12,210	–	–	﹤0.01%	165
2025 Q2	$14.7K	Hold	12,210	–	–	﹤0.01%	170
2025 Q1	$13.2K	Hold	12,210	–	–	﹤0.01%	149
2024 Q4	$21.4K	Hold	12,210	–	–	﹤0.01%	143
2024 Q3	$23.6K	Hold	12,210	–	–	﹤0.01%	134
2024 Q2	$21.6K	Hold	12,210	–	–	﹤0.01%	133
2024 Q1	$33.1K	Buy	+12,210	New	+$29.5K	0.01%	131

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Evolution Wealth Advisors's LAB Position: Q1 2026 in Review

Evolution Wealth Advisors held its Standard BioTools (LAB) position steady in Q1 2026 at 12,210 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #176.

Evolution Wealth Advisors first reported a position in LAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $33.1K in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

Evolution Wealth Advisors held 12,210 shares of Standard BioTools worth $11.2K as of Q1 2026.
Evolution Wealth Advisors left its Standard BioTools share count unchanged in Q1 2026.
Standard BioTools made up ﹤0.01% of Evolution Wealth Advisors's portfolio in Q1 2026, its #176 holding.
Evolution Wealth Advisors first reported a position in Standard BioTools in Q1 2024 and has held it in 9 quarters since.
Evolution Wealth Advisors's Standard BioTools position peaked at $33.1K in Q1 2024.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Evolution Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.